DK41590A - Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme - Google Patents

Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme Download PDF

Info

Publication number
DK41590A
DK41590A DK041590A DK41590A DK41590A DK 41590 A DK41590 A DK 41590A DK 041590 A DK041590 A DK 041590A DK 41590 A DK41590 A DK 41590A DK 41590 A DK41590 A DK 41590A
Authority
DK
Denmark
Prior art keywords
molecules
activation
procedures
preparation
same
Prior art date
Application number
DK041590A
Other languages
Danish (da)
English (en)
Other versions
DK41590D0 (da
Inventor
Robert M Wydro
Catherine L Oppenheimer
Debra A Barngrover
Dawn T Ferrara
William R Dackowski
Gregory M Landes
Nancy A Capalucci
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of DK41590D0 publication Critical patent/DK41590D0/da
Publication of DK41590A publication Critical patent/DK41590A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK041590A 1987-05-18 1990-02-16 Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme DK41590A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5136687A 1987-05-18 1987-05-18
PCT/US1988/002083 WO1989012685A1 (en) 1987-05-18 1988-06-17 Improved protein c molecules and method for making and activating same

Publications (2)

Publication Number Publication Date
DK41590D0 DK41590D0 (da) 1990-02-16
DK41590A true DK41590A (da) 1990-04-11

Family

ID=22208746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK041590A DK41590A (da) 1987-05-18 1990-02-16 Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme

Country Status (4)

Country Link
EP (1) EP0380508A4 (ja)
JP (1) JPH03501921A (ja)
DK (1) DK41590A (ja)
WO (1) WO1989012685A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU905784D0 (en) * 1989-09-05 1991-03-28 Lilly Co Eli Process for activating protein c
ES2113878T3 (es) * 1989-12-29 1998-05-16 Zymogenetics Inc Proteina c hibrida.
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
EP0512011B1 (en) * 1990-01-26 1994-04-06 IMMUNO Aktiengesellschaft Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process
JP3043558B2 (ja) * 1993-10-29 2000-05-22 財団法人化学及血清療法研究所 ヒト活性化プロテインｃ調製物及びその製法
WO2004113385A1 (en) * 2003-06-20 2004-12-29 Maxygen Holdings Ltd. Protein c propeptide variants
EP1670947B1 (en) 2003-09-23 2015-04-01 University Of North Carolina At Chapel Hill Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin k epoxide reductase gene and warfarin dosage
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
EP1861499A4 (en) 2005-03-15 2008-09-03 Univ North Carolina METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ACTIVE PROTEINS DEPENDENT ON VITAMIN K
KR20130140221A (ko) 2005-04-13 2013-12-23 아스트라제네카 아베 감마 카르복실화를 필요로 하는 단백질 생산용 벡터를 포함하는 숙주 세포
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
WO2012088222A2 (en) 2010-12-21 2012-06-28 The University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin k-dependent proteins
CN104394883B (zh) 2012-07-04 2017-05-31 悉尼大学 炎性皮肤病症的治疗
CA2946028C (en) 2014-04-16 2022-10-11 Zz Biotech Llc Treatment of abnormal cutaneous scarring

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189534A (en) * 1976-11-11 1980-02-19 Massachusetts Institute Of Technology Cell culture microcarriers
US4579821A (en) * 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4751084A (en) * 1986-02-26 1988-06-14 Monsanto Company Tissue plasminogen activator from normal human colon cells
EP0245949B1 (en) * 1986-04-09 1997-10-29 Eli Lilly And Company A method of using eukaryotic expression vectors comprising the bk virus enhancer
IL82648A0 (en) * 1986-05-27 1987-11-30 Lilly Co Eli Human protein s,a plasma protein regulator of hemostasis
ZA889497B (en) * 1987-12-28 1990-08-29 Lilly Co Eli Vectors and compounds for expression of zymogen forms of human protein c

Also Published As

Publication number Publication date
WO1989012685A1 (en) 1989-12-28
DK41590D0 (da) 1990-02-16
EP0380508A1 (en) 1990-08-08
JPH03501921A (ja) 1991-05-09
EP0380508A4 (en) 1991-04-03

Similar Documents

Publication Publication Date Title
DK39885D0 (da) Paaviselige molekyler samt fremgangsmaade til deres fremstilling og anvendelse
DK149312C (da) Immobiliserede proteinagtige praeparater, fremgangsmaade til fremstilling af saadanne samt anvendelse af saadanne praeparater
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK299087D0 (da) Proteins and derivatives thereof
FI881743A0 (fi) Menetelmä bifunktionaalisten proteiinien valmistamiseksi
DK41590A (da) Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme
DK243087D0 (da) Fremgangsmaade til bestraaling af topas samt det vedfremgangsmaaden opnaaede produkt
DK397388A (da) Derivater af n-aminobutyl-n-phenylarylamider til terapeutisk anvendelse samt fremgangsmaade til fremstilling af saadanne derivater
DK661288D0 (da) Iminophenylthiazolidiner, fremgangsmaade til deres fremstilling samt anvendelsen heraf
DK448887D0 (da) Hidtil ukendt amylaseenzym og fremgangsmaade til fremstilling af samme
DK675389A (da) Terapeutiske praeparater til forebyggelse af fibrinaflejringer
NO893794D0 (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
NO884324D0 (no) Fremgangsmaate til fremstilling av reninhemmende peptider og deres anvendelse.
DK69387A (da) Cyanoderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne
NO881502D0 (no) Rekombinante htlv-111 proteiner og anvendelse av disse.
DK239385A (da) Krystallinske metallophosphoaluminater samt fremgangsmaade til fremstilling og anvendelse af disse
DK693287A (da) Fremgangsmaade til fremstilling af lipophile aminosyrederivater, samt herved opnaaede aminosyrederivater og anvendelsen heraf
NO891926L (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
DK701588D0 (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK120687D0 (da) Hoej-produktiv bakterie-fermentation samt fremgangsmaade til fremstilling af proteinmateriale
NO893796L (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
DK450087D0 (da) Fremgangsmaade til fremstilling af proteiner
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK342287D0 (da) Protein med prokoagulerende virkning,fremgangsmaade til fremstilling af et saadant protein og farmaceutisk praeparat indeholdende proteinet

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment